Quantcast

Latest Amyotrophic lateral sclerosis Stories

2014-09-30 23:14:17

New video from the National Hospice and Palliative Care Organization's “Moments of Life” campaign shows the compassion provided by hospice to a couple facing ALS. Alexandria, VA (PRWEB) September 30, 2014 Visit Pam and Steve’s quiet home in the Philadelphia neighborhood of Chestnut Hill and you will find a loving couple facing the most monumental challenge of their life together, Amyotrophic Lateral Sclerosis. Steve was diagnosed with ALS – more commonly known as ALS or Lou...

2014-09-30 12:30:15

"Food for Thought" to Promote Education, Fundraising for Rare Brain Disease RADNOR, Pa., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Supporters from throughout the U.S. will host events during the 2(nd) Annual "Food for Thought" campaign from October 5-12, with the goal of raising awareness about frontotemporal degeneration (FTD). FTD is an often-misdiagnosed, progressive neurodegenerative disease affecting 50,000 people in the United States, and is the leading cause of dementia in adults...

2014-09-30 08:32:34

CLEVELAND, Sept. 30, 2014 /PRNewswire/ -- Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has completed the enrollment of the post-approval study of its NeuRx DPS® System for ALS patients. The last patient needed to meet the FDA enrollment requirement was implanted over a month and a half ahead of schedule. The NeuRx DPS®, which is the only medical device approved by the FDA specifically for ALS patients, is a humanitarian device that obtained approval at...

2014-09-26 08:24:55

Presentation and Webcast Scheduled for September 26th at 3:30 PM ET LOS ANGELES, Sept. 26, 2014 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company's presentation time at BioCentury's 2014 NewsMakers in the Biotech Industry Conference. David J. Haen, Vice President, Business Development, will present on Friday, September 26(th) at 3:30 p.m. ET. A live and archived...

2014-09-23 23:13:56

In his new role, Philip plans to use his position on the Board to advance MSA awareness, educate health professionals and collaborate with other charities to make government funding available to MSA patients. Philip is already well known in the MSA community for his tireless campaign with Tim’s MSA Shoe, an iconic symbol of Multiple System Atrophy. Detroit MI (PRWEB) September 23, 2014 The Multiple System Atrophy Coalition, a growing nonprofit 501(c) 3 organization dedicated to...

2014-09-23 23:08:44

Home Care Assistance – Toronto/York Region (HomeCareAssistance-Toronto.com), the leading provider of non-medical, in-home senior care in the Greater Toronto Area, is weighing in on the recent case of a British Columbia woman diagnosed with dementia taking her own life. Toronto, Canada (PRWEB) September 23, 2014 Home Care Assistance – Toronto/York Region (HomeCareAssistance-Toronto.com), the leading provider of non-medical, in-home senior care in the Greater Toronto Area, is weighing...

2014-09-23 12:35:49

Employees and Families Raise Funds, Awareness at Annual Family Picnic WASHINGTON, Sept. 23, 2014 /PRNewswire/ -- MicroPact Inc., the global leader in Data-First(TM) Case Management and Business Process Management (BPM) software, is proud to do its part to help find a cure for ALS, commonly referred to as Lou Gehrig's disease, by taking part in the ALS Ice Bucket Challenge at the company's annual family picnic Sept. 6. Members of MicroPact's Senior Management Team joined dozens of...

2014-09-22 08:29:39

Some Patients Continue to Show Slowed Disease Progression or Improvement Three Years Post-Transplant GERMANTOWN, Md., Sept. 22, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathan D. Glass, MD, site investigator at Emory University, presented long-term follow up data on the Phase I trial testing NSI-566 human neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The presentation, which occurred at the Annual...

2014-09-19 08:25:30

LOS ANGELES, Sept. 19, 2014 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that David J. Haen, Vice President, Business Development, will present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference on Friday, September 26(th) at 4:00 p.m. Eastern Time. The conference will take place at the Millennium Broadway Hotel in New York City. A live and archived webcast of the...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related